Whitehawk Therapeutics, Inc. (WHWK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5M 5M 7.5M Q3 '24: 7.2M Q4 '24: 7.2M Q1 '25: 7.1M Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 2.5M 5M 7.5M Q3 '24: 6.4M Q4 '24: 6.4M Q1 '25: 6.4M Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -13.4M Q4 '24: -18.9M Q1 '25: -15.2M Q2 '25: -54.7M Q3 '25: -19.5M Q4 '25: -24.9M Q1 '26: -23.5M Q2 '26: -18.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '24: -12.5M Q4 '24: -18.3M Q1 '25: 73M Q2 '25: -52.6M Q3 '25: -17.7M Q4 '25: -23.3M Q1 '26: -22.2M Q2 '26: -16.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 300K 600K 900K Q3 '24: 804K Q4 '24: 790K Q1 '25: 760K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -15.7M Q4 '24: -15.1M Q1 '25: -11.9M Q2 '25: -53M Q3 '25: -15.4M Q4 '25: -17.2M Q1 '26: -22.2M Q2 '26: -14.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -15.9M Q4 '24: -15.2M Q1 '25: -12.4M Q2 '25: -53M Q3 '25: -15.4M Q4 '25: -17.2M Q1 '26: -22.2M Q2 '26: -14.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '24: 27M Q2 '24: 27M Q3 '24: 27M Q1 '25: 39.9M Q2 '25: 69.1M Q3 '25: 69.2M Q1 '26: 69.2M Q2 '26: 82.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.70 -1.80 -0.90 0.00 0.90 1.80 2.70 Q3 '24: -2.28 Q4 '24: -2.36 Q1 '25: 0.15 Q2 '25: -0.07 Q3 '25: 0.13 Q4 '25: -0.33 Q1 '26: -2.48 Q2 '26: -1.92 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.